了解质母细胞瘤微环境:利用细胞外基质来提高免疫疗法的疗效
Jimena Collado1, Lauren Boland1,2, Jared T Ahrendsen3
1Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Frontiers in immunology
|February 21, 2024
概括
质母细胞瘤 (GBM) 是一种致命的脑癌. 针对其复杂的瘤微环境,特别是细胞外基质,可以提高免疫治疗的有效性.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 质母细胞瘤 (GBM) 是最常见和最致命的恶性脑瘤,五年生存率低于10%.
- 目前的免疫疗法在很大程度上对GBM无效,原因是它的异质和免疫抑制瘤微环境 (TME).
研究的目的:
- 在GBM TME中研究细胞外基质 (ECM) 的免疫调节作用.
- 确定ECM如何在GBM中促进免疫抑制.
- 阐明增强GBM免疫疗法的潜在治疗点.
主要方法:
- 文献综述侧重于在GBM中ECM,TME和免疫细胞之间的相互作用.
- 对GBM病理生理学和治疗耐药性的现有研究进行分析.
主要成果:
- ECM是GBM TME的关键组成部分,积极调解免疫抑制.
- ECM的组成和结构影响免疫细胞透和瘤内的功能.
结论:
- 针对ECM在免疫调节中的作用,为增强GBM免疫疗法提供了一个有希望的策略.
- 阐明这些相互作用可以导致开发新的治疗点,以更有效地治疗GBM.
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524